Literature DB >> 9788705

Human eosinophil granule major basic protein and its novel homolog.

D A Plager1, S Stuart, G J Gleich.   

Abstract

Human MBP is associated with an array of in vitro cytotoxic and cytostimulatory activities, mediated in part by its strong basicity. It is most prominently found in the eosinophil, but is also present in placental X cells and placental-site giant cells during pregnancy. Pathologically, its pattern of tissue deposition and its ability to induce characteristic pathophysiologic changes, such as bronchial hyperreactivity and vasopermeability, strongly suggest a role for MBP in allergic and eosinophilic diseases. The role of MBP in protection from helminthic disease is also evident. Here, we present information on a novel homolog of eosinophil granule MBP with biologic activities similar to that of MBP. However, results from experiments on eosinophil granules suggest that the quantity of the homolog present in the eosinophil granule is significantly less than that of MBP itself. Further, preliminary experiments indicate that the two proteins are not synergistic in terms of their cytotoxic and cytostimulatory biologic activities. Future experiments must determine whether the MBP homolog is deposited at sites of tissue damage and can be detected in biologic fluids at concentrations required for biologic activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788705     DOI: 10.1111/j.1398-9995.1998.tb04937.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  6 in total

Review 1.  Pathogenesis and classification of eosinophil disorders: a review of recent developments in the field.

Authors:  Peter Valent; Gerald J Gleich; Andreas Reiter; Florence Roufosse; Peter F Weller; Andrzej Hellmann; Georgia Metzgeroth; Kristin M Leiferman; Michel Arock; Karl Sotlar; Joseph H Butterfield; Sabine Cerny-Reiterer; Matthias Mayerhofer; Peter Vandenberghe; Torsten Haferlach; Bruce S Bochner; Jason Gotlib; Hans-Peter Horny; Hans-Uwe Simon; Amy D Klion
Journal:  Expert Rev Hematol       Date:  2012-04       Impact factor: 2.929

2.  T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis.

Authors:  Florian Rieder; Ilche Nonevski; Jie Ma; Zhufeng Ouyang; Gail West; Cheryl Protheroe; Giovanni DePetris; Anja Schirbel; James Lapinski; John Goldblum; Tracey Bonfield; Rocio Lopez; Karen Harnett; James Lee; Ikuo Hirano; Gary Falk; Piero Biancani; Claudio Fiocchi
Journal:  Gastroenterology       Date:  2014-01-28       Impact factor: 22.682

3.  Lack of eosinophil peroxidase or major basic protein impairs defense against murine filarial infection.

Authors:  Sabine Specht; Michael Saeftel; Manuela Arndt; Elmar Endl; Bettina Dubben; Nancy A Lee; James J Lee; Achim Hoerauf
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

4.  ICON: Eosinophil Disorders.

Authors:  Peter Valent; Amy D Klion; Lanny J Rosenwasser; Michel Arock; Bruce S Bochner; Joseph H Butterfield; Jason Gotlib; Torsten Haferlach; Andrzej Hellmann; Hans-Peter Horny; Kristin M Leiferman; Georgia Metzgeroth; Kenji Matsumoto; Andreas Reiter; Florence Roufosse; Marc E Rothenberg; Hans-Uwe Simon; Karl Sotlar; Peter Vandenberghe; Peter F Weller; Gerald J Gleich
Journal:  World Allergy Organ J       Date:  2012-12       Impact factor: 4.084

5.  Six-month low level chlorine dioxide gas inhalation toxicity study with two-week recovery period in rats.

Authors:  Akinori Akamatsu; Cheolsung Lee; Hirofumi Morino; Takanori Miura; Norio Ogata; Takashi Shibata
Journal:  J Occup Med Toxicol       Date:  2012-02-21       Impact factor: 2.646

6.  Overview on the pathomechanisms of allergic rhinitis.

Authors:  Ruby Pawankar; Sachiko Mori; Chika Ozu; Satoko Kimura
Journal:  Asia Pac Allergy       Date:  2011-10-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.